Continuous-flow left ventricular assist devices (LVADs) have gained tremendous acceptance for the treatment of end-stage heart failure patients. Among different versions, axial flow and centrifugal flow LVADs have shown remarkable potential for clinical implants. It is also very crucial to know which device serves its purpose better to treat heart failure patients. A thorough comparison of axial and centrifugal LVADs, which may guide doctors in deciding before the implant, still lacks in the literature. In this work, an assessment of axial and centrifugal LVADs has been made to suggest a better device by comparing their engineering, clinical, and technological development of design aspects. Hydrodynamic and hemodynamic aspects for both types of pumps are discussed along with their biocompatibility, bearing types, and sizes. It has been observed numerically that centrifugal LVADs perform better over axial LVADs in every engineering aspect like higher hydraulic efficiency, better characteristics curve, lesser power intake, and also lesser blood damage. However, the clinical outcomes suggest that centrifugal LVADs experience higher events of infections, renal, and respiratory dysfunction. In contrast, axial LVADs encountered higher bleeding and cardiac arrhythmia. Moreover, recent technological developments suggested that magnetic type bearings along with biocompatible coating improve the life of LVADs.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/aor.13914 | DOI Listing |
Hellenic J Cardiol
October 2024
Heart Failure and Transplant Unit, Onassis Cardiac Surgery Centre, 356 Syngrou Avenue, Kallithea, Attica 176 74, Greece.
AANA J
August 2024
is a senior nurse scientist in Cleveland Clinic's Office of Nursing Research and Innovation, and consultant staff at Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio. Email:
Safely anesthetizing patients with left ventricular assist devices (LVADs) can be intimidating, particularly for novice anesthesia providers. Given the variety of complex issues anesthesia providers may encounter with patients, it would be impractical to expect expertise in every population. To combat the inevitable loss of knowledge, education experts recommend active learning techniques, including test-enhanced learning, active recall, and spaced repetition.
View Article and Find Full Text PDFJ Clin Med
May 2024
George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, UT 84148, USA.
Centrifugal-flow left ventricular assist devices (CF-LVADs) have improved morbidity and mortality for their recipients. Hospital readmissions remain common, negatively impacting quality of life and survival. We sought to identify risk factors associated with hospital readmissions among patients with CF-LVADs.
View Article and Find Full Text PDFJ Biomech Eng
October 2024
Clean Mobility & Thermofluids, Universitat Politècnica de València, Camino de Vera, s/n, València 46022, Spain.
Computational fluid dynamics (CFD) simulations are widely used to develop and analyze blood-contacting medical devices such as left ventricular assist devices (LVADs). This work presents an analysis of the transient behavior of two centrifugal LVADs with different designs: HeartWare VAD and HeartMate3. A scale-resolving methodology is followed through Large Eddy Simulations, which allows for the visualization of turbulent structures.
View Article and Find Full Text PDFJ Chest Surg
March 2024
Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Background: Left ventricular assist devices (LVADs) are widely employed as a therapeutic option for end-stage heart failure. We evaluated the outcomes associated with centrifugal-flow LVAD implantation, comparing 2 device models: the Heartmate 3 (HM3) and the Heartware Ventricular Assist Device (HVAD).
Methods: Data were collected from patients who underwent LVAD implantation between June 1, 2015 and December 31, 2022.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!